Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

2.

Constitutive expression of ULBP-4 on monocytes regulates NK cell NKG2D expression.

Sharma N, Markiewicz MA.

Blood Adv. 2019 May 28;3(10):1563-1567. doi: 10.1182/bloodadvances.2018025742. No abstract available.

3.

Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer.

Goodman ML, Trinca GM, Walter KR, Papachristou EK, D'Santos CS, Li T, Liu Q, Lai Z, Chalise P, Madan R, Fan F, Markiewicz MA, Jin VX, Carroll JS, Hagan CR.

J Immunol. 2019 May 15;202(10):3076-3086. doi: 10.4049/jimmunol.1801152. Epub 2019 Apr 1.

PMID:
30936295
4.

Contribution of YjbIH to Virulence Factor Expression and Host Colonization in Staphylococcus aureus.

Austin CM, Garabaglu S, Krute CN, Ridder MJ, Seawell NA, Markiewicz MA, Boyd JM, Bose JL.

Infect Immun. 2019 May 21;87(6). pii: e00155-19. doi: 10.1128/IAI.00155-19. Print 2019 Jun.

PMID:
30885928
5.

Interplay of Nitric Oxide Synthase (NOS) and SrrAB in Modulation of Staphylococcus aureus Metabolism and Virulence.

James KL, Mogen AB, Brandwein JN, Orsini SS, Ridder MJ, Markiewicz MA, Bose JL, Rice KC.

Infect Immun. 2019 Jan 24;87(2). pii: e00570-18. doi: 10.1128/IAI.00570-18. Print 2019 Feb.

PMID:
30420450
6.

A Protective Role for NKG2D-H60a Interaction via Homotypic T Cell Contact in Nonobese Diabetic Autoimmune Diabetes Pathogenesis.

Trembath AP, Sharma N, Raju S, Polić B, Markiewicz MA.

Immunohorizons. 2017 Nov 1;1(9):198-212. doi: 10.4049/immunohorizons.1700011. Epub 2017 Nov 7.

7.

More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells.

Trembath AP, Markiewicz MA.

Front Immunol. 2018 Feb 12;9:231. doi: 10.3389/fimmu.2018.00231. eCollection 2018. Review.

8.

NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.

Sharma N, Trinidad CV, Trembath AP, Markiewicz MA.

J Immunol. 2017 Oct 15;199(8):2865-2872. doi: 10.4049/jimmunol.1700647. Epub 2017 Sep 11.

9.

Generation of a Stable Plasmid for In Vitro and In Vivo Studies of Staphylococcus Species.

Krute CN, Krausz KL, Markiewicz MA, Joyner JA, Pokhrel S, Hall PR, Bose JL.

Appl Environ Microbiol. 2016 Dec 1;82(23):6859-6869. doi: 10.1128/AEM.02370-16. Epub 2016 Sep 16.

10.

NKG2D-NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In Vivo.

Raju S, Kretzmer LZ, Koues OI, Payton JE, Oltz EM, Cashen A, Polic B, Schreiber RD, Shaw AS, Markiewicz MA.

J Immunol. 2016 Jun 1;196(11):4805-13. doi: 10.4049/jimmunol.1501982. Epub 2016 May 2.

11.

Role of NKG2D in obesity-induced adipose tissue inflammation and insulin resistance.

Chung JJ, Markiewicz MA, Polić B, Shaw AS.

PLoS One. 2014 Oct 15;9(10):e110108. doi: 10.1371/journal.pone.0110108. eCollection 2014.

12.

A dual function of NKG2D ligands in NK-cell activation.

Cheney EE, Wise EL, Bui JD, Schreiber RD, Carayannopoulos LN, Spitzer D, Zafirova B, Polic B, Shaw AS, Markiewicz MA.

Eur J Immunol. 2012 Sep;42(9):2452-8. doi: 10.1002/eji.201141849. Epub 2012 Jul 27.

13.

RAE1ε ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition.

Markiewicz MA, Wise EL, Buchwald ZS, Pinto AK, Zafirova B, Polic B, Shaw AS.

Immunity. 2012 Jan 27;36(1):132-41. doi: 10.1016/j.immuni.2011.11.014. Epub 2012 Jan 12.

14.

A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet.

King J, McCall M, Cannella A, Markiewicz MA, James A, Hood CB, Acosta EP.

J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):e130-2. No abstract available.

PMID:
22046602
15.

Kinase suppressor of Ras 1 is required for full ERK activation in thymocytes but not for thymocyte selection.

Filbert EL, Nguyen A, Markiewicz MA, Fowlkes BJ, Huang YH, Shaw AS.

Eur J Immunol. 2010 Nov;40(11):3226-34. doi: 10.1002/eji.201040349. Epub 2010 Sep 24.

16.

Antiemesis. Clinical Practice Guidelines in Oncology.

Ettinger DS, Armstrong DK, Barbour S, Berger MJ, Bierman PJ, Bradbury B, Ellis G, Kirkegaard S, Kloth DD, Kris MG, Lim D, Markiewicz MA, Nabati L, Nesheiwat C, Rugo HS, Sorscher SM, Stucky-Marshal L, Todaro B, Urba S.

J Natl Compr Canc Netw. 2009 May;7(5):572-95. No abstract available.

PMID:
19460282
17.

New roles revealed for T cells and DCs in glomerulonephritis.

Kim AH, Markiewicz MA, Shaw AS.

J Clin Invest. 2009 May;119(5):1074-6.

18.

IL-12 enhances CTL synapse formation and induces self-reactivity.

Markiewicz MA, Wise EL, Buchwald ZS, Cheney EE, Hansen TH, Suri A, Cemerski S, Allen PM, Shaw AS.

J Immunol. 2009 Feb 1;182(3):1351-61.

19.

The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality.

Cemerski S, Das J, Giurisato E, Markiewicz MA, Allen PM, Chakraborty AK, Shaw AS.

Immunity. 2008 Sep 19;29(3):414-22. doi: 10.1016/j.immuni.2008.06.014. Epub 2008 Aug 28.

20.

The p815 mastocytoma tumor model.

Gajewski TF, Markiewicz MA, Uyttenhove C.

Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.4. doi: 10.1002/0471142735.im2004s43.

PMID:
18432777
21.

The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse.

Cemerski S, Das J, Locasale J, Arnold P, Giurisato E, Markiewicz MA, Fremont D, Allen PM, Chakraborty AK, Shaw AS.

Immunity. 2007 Mar;26(3):345-55. Epub 2007 Mar 8.

22.

Antiemesis.

Ettinger DS, Bierman PJ, Bradbury B, Comish CC, Ellis G, Ignoffo RJ, Kirkegaard S, Kloth DD, Kris MG, Lim D, Markiewicz MA, McNulty R, Nabati L, Todaro B, Urba S, Yowell S; National comprehensive Cancer Network (NCCN).

J Natl Compr Canc Netw. 2007 Jan;5(1):12-33. No abstract available.

PMID:
17239323
23.

Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.

Markiewicz MA, Carayannopoulos LN, Naidenko OV, Matsui K, Burack WR, Wise EL, Fremont DH, Allen PM, Yokoyama WM, Colonna M, Shaw AS.

J Immunol. 2005 Sep 1;175(5):2825-33.

24.

Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression.

Achilefu S, Bloch S, Markiewicz MA, Zhong T, Ye Y, Dorshow RB, Chance B, Liang K.

Proc Natl Acad Sci U S A. 2005 May 31;102(22):7976-81. Epub 2005 May 23.

25.

ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo.

Blank C, Brown I, Kacha AK, Markiewicz MA, Gajewski TF.

J Immunol. 2005 Mar 15;174(6):3416-20.

26.
27.

Antiemesis clinical practice guidelines in oncology.

Ettinger DS, Bierman PJ, Bradbury B, Ellis G, Ignoffo RJ, Kirkegaard S, Kloth D, Krauss A, Kris MG, Lim D, Markiewicz MA, McNulty R, Noonan K, Stucky-Marshall L, Todaro B, Urba S, Yowell S; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2004 Sep;2(5):470-90. No abstract available.

PMID:
19780255
28.

Immunotherapy for urological malignancies.

Krejci KG, Markiewicz MA, Kwon ED.

J Urol. 2004 Feb;171(2 Pt 1):870-6. Review.

PMID:
14713844
29.

Death of peripheral CD8+ T cells in the absence of MHC class I is Fas-dependent and not blocked by Bcl-xL.

Markiewicz MA, Brown I, Gajewski TF.

Eur J Immunol. 2003 Oct;33(10):2917-26.

30.

CD4+ T cell matters in tumor immunity.

Velders MP, Markiewicz MA, Eiben GL, Kast WM.

Int Rev Immunol. 2003 Mar-Apr;22(2):113-40. Review.

PMID:
12962272
31.

Advances in immunotherapy for prostate cancer.

Markiewicz MA, Kast WM.

Adv Cancer Res. 2003;87:159-94. Review.

PMID:
12641276
32.

Antigen-specific blockade of T cells in vivo using dimeric MHC peptide.

O'Herrin SM, Slansky JE, Tang Q, Markiewicz MA, Gajewski TF, Pardoll DM, Schneck JP, Bluestone JA.

J Immunol. 2001 Sep 1;167(5):2555-60.

33.

Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A.

Markiewicz MA, Fallarino F, Ashikari A, Gajewski TF.

Int Immunol. 2001 May;13(5):625-32.

PMID:
11312250
34.

The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen.

Urban D, Irwin W, Kirk M, Markiewicz MA, Myers R, Smith M, Weiss H, Grizzle WE, Barnes S.

J Urol. 2001 Jan;165(1):294-300.

PMID:
11125428
35.

Cutting edge: spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice.

Kacha AK, Fallarino F, Markiewicz MA, Gajewski TF.

J Immunol. 2000 Dec 1;165(11):6024-8.

36.

The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response.

Markiewicz MA, Gajewski TF.

Crit Rev Oncog. 1999;10(3):247-60. Review.

PMID:
10468184
37.

Serum and urinary isoflavonoids and their metabolites in elderly men on diets supplemented with beverages containing untreated and alcohol-extracted soy protein.

Smith M, Kirk M, Weiss H, Irwin W, Markiewicz MA, Urban D, Grizzle WE, Barnes S.

J Med Food. 1999;2(3-4):219-22. doi: 10.1089/jmf.1999.2.219. No abstract available.

PMID:
19281385
38.

Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules.

Markiewicz MA, Girao C, Opferman JT, Sun J, Hu Q, Agulnik AA, Bishop CE, Thompson CB, Ashton-Rickardt PG.

Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3065-70.

Supplemental Content

Loading ...
Support Center